查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區單細胞多組體學市場：分析與預測（2023-2033）
市場調查報告書
商品編碼
1430512

亞太地區單細胞多組體學市場：分析與預測（2023-2033）

Asia-Pacific Single-Cell Multi Omics Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 93 Pages | 商品交期: 1-5個工作天內

價格
主要市場統計數據
預測期 2023-2033
2023年評估 3億美元
2033年預測 18.5億美元
複合年成長率 20%

亞太地區單細胞多組體學市場規模預計將從 2023 年的 3 億美元增至 2033 年的 18.5 億美元，在 2023-2033 年預測期內複合年成長率為 20.00%。

該市場的推動因素包括：在大規模基因組研究中擴大使用單細胞 RNA定序(Sc-RNA)、向採用單細胞多組體學方法進行疾病篩檢和診斷的個性化醫療的轉變以及單細胞藥物開發中的 RNA 定序：成長是由多種因素推動的，包括多組體學採用的增加。

由於幾個關鍵因素，亞太地區 (APAC) 單細胞多組體學市場正在顯著成長。這包括全部區域基因組學研究中擴大採用單細胞多組體學技術。隨著個人化醫療受到關注，人們開始轉向利用單細胞多組體學方法進行疾病篩檢和診斷。此外，單細胞多組體學在藥物開發過程中的應用在亞太地區呈現上升趨勢。支持舉措研究和醫療基礎設施進步的政府措施進一步促進了市場成長。由於人口眾多且對精準醫學的日益關注，亞太地區單細胞多體學市場為研究機構、製藥公司和醫療保健提供者做好了準備，以更好地了解疾病並開發針對個別患者的標靶治療。

本報告探討了亞太地區單細胞多組體學市場，概述了市場、國家趨勢以及參與該市場的公司概況。

目錄

執行摘要

調查範圍

第1章 市場

  • 市場展望
  • 市場概況
  • 產業展望
  • COVID-19 的影響
  • 業務動態

第2章 單細胞多組體學市場（按地區）

  • 亞太地區

第3章市場－競爭基準化分析與公司概況

  • 競爭基準化分析
    • 關鍵策略和發展
    • 市場佔有率分析
    • 成長佔有率分析
    • 企業視覺圖形
    • 活躍於多組體學生態系統的公司
  • 公司簡介
    • BGI Group
    • Shilps Sciences
    • Takara Bio Inc.
Product Code: BHP1882SS

The Asia-Pacific Single-Cell Multi Omics Market Expected to Reach $1.85 Billion by 2033

Introduction to Asia-Pacific Single-Cell Multi-Omics Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$0.30 Billion
2033 Forecast$1.85 Billion
CAGR20%

The Asia-Pacific single-cell multi-omics market is projected to reach $1.85 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 20.00% during the forecast period 2023-2033. The market is growing owing to various factors, such as the rising use of single-cell RNA sequencing (Sc-RNA) in large-scale genomics studies, a transition toward personalized medicine employing the single-cell multi-omics approach for disease screening and diagnostics, and increased uptake of single-cell multi-omics in drug development.

Market Introduction

The Asia-Pacific (APAC) single-cell multi-omics market is experiencing notable growth, driven by several key factors. This includes the increasing adoption of single-cell multi-omics technologies in genomics studies across the region. As personalized medicine gains prominence, there's a growing shift towards utilizing single-cell multi-omics approaches for disease screening and diagnostics. Moreover, the APAC region is witnessing a rising trend in the application of single-cell multi-omics in drug development processes. Government initiatives supporting genomic research and advancements in healthcare infrastructure further contribute to market growth. With a vast population and increasing focus on precision medicine, the APAC single-cell multi-omics market presents promising opportunities for research institutions, pharmaceutical companies, and healthcare providers to enhance understanding of diseases and develop targeted therapies tailored to individual patients.

Market Segmentation:

Segmentation 1: by Country

  • China
  • Japan
  • India
  • Australia
  • Singapore
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.

Competitive Strategy: The APAC single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in various applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • BGI Group
  • Shilps Sciences
  • Takara Bio Inc.

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1 Market

  • 1.1 Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion and Exclusion Criteria
  • 1.2 Market Overview
    • 1.2.1 Key Findings
    • 1.2.2 Current Market Scenario
      • 1.2.2.1 For Researchers
      • 1.2.2.2 For Diagnostics
  • 1.3 Industry Outlook
    • 1.3.1 Regulatory Framework
    • 1.3.2 Patent Analysis
      • 1.3.2.1 Awaited Technological Developments
      • 1.3.2.2 Patent Filing Trend (by Country)
      • 1.3.2.3 Patent Filing Trend (by Year)
    • 1.3.3 Key Trends
      • 1.3.3.1 Advancements in Imaging Techniques for Single-Cell Sequencing
      • 1.3.3.2 Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
      • 1.3.3.3 Increased Development of Advanced Solution Based on Single-Cell Technology
    • 1.3.4 Opportunity Assessment
    • 1.3.5 Product Benchmarking
    • 1.3.6 Clinical Trials
  • 1.4 COVID-19 Impact
    • 1.4.1 Pre-COVID-19
    • 1.4.2 During COVID-19
    • 1.4.3 Post COVID-19
  • 1.5 Business Dynamics
    • 1.5.1 Impact Analysis
    • 1.5.2 Business Drivers
      • 1.5.2.1 Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
      • 1.5.2.2 Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
      • 1.5.2.3 Increasing Use of Single-Cell Multi-Omics for Drug Development
      • 1.5.2.4 Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
    • 1.5.3 Business Restraints
      • 1.5.3.1 High Cost of Single-Cell Analysis and Sequencing
      • 1.5.3.2 Limited Availability of Large Online Data Storage and Analysis Platforms
    • 1.5.4 Business Opportunities
      • 1.5.4.1 Expansion into New Research Applications, Such as Single-Cell Metabolomics
      • 1.5.4.2 Increasing Adoption of Genomic-Based Medicine in Emerging Nations

2 Single-Cell Multi-Omics Market (by Region)

  • 2.1 Asia-Pacific
    • 2.1.1 Key Findings and Opportunity Assessment
    • 2.1.2 Market Dynamics
      • 2.1.2.1 Impact Analysis
    • 2.1.3 Sizing and Forecast Analysis
      • 2.1.3.1 Asia-Pacific Single-Cell Multi-Omics Market (by Country)
        • 2.1.3.1.1 China
        • 2.1.3.1.2 Japan
        • 2.1.3.1.3 India
        • 2.1.3.1.4 Singapore
        • 2.1.3.1.5 Australia
        • 2.1.3.1.6 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Benchmarking
    • 3.1.1 Key Strategies and Developments
      • 3.1.1.1 Funding Activities
      • 3.1.1.2 New Offerings
      • 3.1.1.3 Mergers and Acquisitions
      • 3.1.1.4 Partnership, Collaboration, and Business Expansion
    • 3.1.2 Market Share Analysis
    • 3.1.3 Growth Share Analysis
      • 3.1.3.1 By Application
      • 3.1.3.2 By Omics Type
      • 3.1.3.3 By Product Type
    • 3.1.4 Visual Graphics of the Companies
    • 3.1.5 Multi-Omics Ecosystem Active Players
  • 3.2 Company Profiles
    • 3.2.1 BGI Group
      • 3.2.1.1 Company Overview
      • 3.2.1.2 Role of BGI Group in the Single-Cell Multi-Omics Market
      • 3.2.1.3 Financials
      • 3.2.1.4 Analyst Perspective
    • 3.2.2 Shilps Sciences
      • 3.2.2.1 Company Overview
      • 3.2.2.2 Role of Shilps Sciences in the Single-Cell Multi-Omics Market
      • 3.2.2.3 Analyst Perspective
    • 3.2.3 Takara Bio Inc.
      • 3.2.3.1 Company Overview
      • 3.2.3.2 Role of Takara Bio Inc. in the Single-Cell Multi-Omics Market
      • 3.2.3.3 Financials
      • 3.2.3.4 Analyst Perspective

List of Figures

  • Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
  • Figure 2: Single-Cell Multi-Omics Market, Impact Analysis
  • Figure 3: Asia-Pacific Single-Cell Multi-Omics Market (by Application), % Share, 2022 and 2033
  • Figure 4: Single-Cell Multi-Omics Market: Research Methodology
  • Figure 5: Primary Research Methodology
  • Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 8: Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
  • Figure 9: Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
  • Figure 10: Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
  • Figure 11: Single-Cell Multi-Omics Market, Impact Analysis
  • Figure 12: Data for Rare Diseases, 2020
  • Figure 13: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
  • Figure 14: Advantages of Multi-Omics in Drug Discovery and Development
  • Figure 15: Cost of Single Cell Sequencing (by Company)
  • Figure 16: Some of the Advancements in Single-Cell Metabolomics
  • Figure 17: Single-Cell Multi-Omics Market Share (by Region)
  • Figure 18: Asia-Pacific Single-Cell Multi-Omics Market Incremental Revenue Opportunity (by Country), $Million, 2023-2033
  • Figure 19: Asia-Pacific Single-Cell Multi-Omics Market, $Billion, 2022-2033
  • Figure 20: Asia-Pacific Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
  • Figure 21: China Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 22: Japan Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 23: India Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 24: Singapore Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 25: Australia Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 26: Rest-of-Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 27: Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
  • Figure 28: Funding Activities, January 2018-March 2023
  • Figure 29: New Offerings, January 2018-March 2023
  • Figure 30: Mergers and Acquisitions, January 2018-March 2023
  • Figure 31: Partnership, Collaboration, and Business expansion, January 2018-March 2023
  • Figure 32: Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
  • Figure 33: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
  • Figure 34: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
  • Figure 35: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
  • Figure 36: Single Cell Multi Omics Market, Visual Graphics of the Companies
  • Figure 37: BGI Genomics.: Product Portfolio
  • Figure 38: BGI Genomics: Overall Financials, $Million, 2020-2022
  • Figure 39: Shilps Sciences: Product Portfolio
  • Figure 40: Takara Bio Inc.: Product Portfolio
  • Figure 41: Takara Bio Inc.: Overall Financials, $Million, 2020-2022
  • Figure 42: Takara Bio Inc.: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 43: Takara Bio Inc.: Net Revenue (by Region), $Million, 2020-2022
  • Figure 44: Takara Bio Inc.: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Single-Cell Multi-Omics Market: Global Regulatory Organization
  • Table 4: Single-Cell Multi-Omics Market, Product Benchmarking
  • Table 5: Single-Cell Multi-Omics Market, Ongoing Clinical Trials
  • Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
  • Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
  • Table 8: Asia-Pacific Single-Cell Multi-Omics Market Dynamics, Impact Analysis
  • Table 9: Multi-Omics Ecosystem Active Players